The current study aims to determine cause-specific survival in patients with Ewing’s sarcoma while reporting clinical risk factors for survival. Patients with Ewing’s sarcoma have decreased cause-specific survival at 10 years when metastatic at presentation, axial tumor location, tumor size > 10 cm, and patient age ≥20 years.

READ FULL ARTICLE Curated publisher From Mdlinx